MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
26.59
-0.11 (-0.41%)
At close: 4:03PM EST
Stock chart is not supported by your current browser
Previous Close26.70
Open26.59
Bid26.64 x 800
Ask26.74 x 800
Day's Range26.48 - 26.81
52 Week Range19.93 - 36.59
Volume1,202,356
Avg. Volume1,029,196
Market Cap2.222B
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Hedge fund seeks to replace board at Mednax, explore sale
    American City Business Journals

    Hedge fund seeks to replace board at Mednax, explore sale

    The Starboard Value hedge fund proposed a new board of directors of Mednax, which could lead to the company exploring a sale. Sunrise-based Mednax (NYSE: MD) is one of the largest public companies in South Florida.

  • Moody's

    MEDNAX, Inc. -- Moody's announces completion of a periodic review of ratings of MEDNAX, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of MEDNAX, Inc. New York, February 13, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of MEDNAX, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Analysts Estimate Mednax (MD) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Mednax (MD) to Report a Decline in Earnings: What to Look Out for

    Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Earnings Preview: Mednax (MD) Q4 Earnings Expected to Decline
    Zacks

    Earnings Preview: Mednax (MD) Q4 Earnings Expected to Decline

    Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Why Should You Retain MEDNAX (MD) Stock in Your Portfolio?
    Zacks

    Why Should You Retain MEDNAX (MD) Stock in Your Portfolio?

    Riding high on its rising revenue stream and inorganic growth profile, MEDNAX (MD) holds potential to benefit its investors.

  • HCA Healthcare Acquires Valify to Rein in Medical Costs
    Zacks

    HCA Healthcare Acquires Valify to Rein in Medical Costs

    HCA Healthcare (HCA) completes the buyout of technology company Valify to identify opportunities for reducing expenses.

  • Why Should You Hold HCA Healthcare in Your Portfolio Now?
    Zacks

    Why Should You Hold HCA Healthcare in Your Portfolio Now?

    Riding high on its growing revenues and a firm capital position, HCA Healthcare (HCA) holds potential to reap benefits for investors.

  • How Many MEDNAX, Inc. (NYSE:MD) Shares Did Insiders Buy, In The Last Year?
    Simply Wall St.

    How Many MEDNAX, Inc. (NYSE:MD) Shares Did Insiders Buy, In The Last Year?

    We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...

  • MEDNAX Expands Further in Florida With Radiology Affiliation
    Zacks

    MEDNAX Expands Further in Florida With Radiology Affiliation

    MEDNAX (MD) forms an association with Boca Radiology Group to strengthen its radiology business in Florida.

  • Were Hedge Funds Right About Buying Mednax Inc. (MD)?
    Insider Monkey

    Were Hedge Funds Right About Buying Mednax Inc. (MD)?

    Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]

  • MEDNAX (MD) Catches Eye: Stock Jumps 8.1%
    Zacks

    MEDNAX (MD) Catches Eye: Stock Jumps 8.1%

    MEDNAX (MD) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

  • Reuters

    PRESS DIGEST - Wall Street Journal - Dec. 11

    The following are the top stories in the Wall Street Journal. - U.S. and Chinese trade negotiators are laying the groundwork for a delay of a fresh round of tariffs set to kick in on Dec. 15, officials on both sides said, as they haggle over how to get Beijing to commit to massive purchases of U.S. farm products on which President Trump is insisting for a near-term deal. - Bloomberg LP's media division is buying CityLab, a website focused on urban planning and the future of city living, from the Atlantic, the first acquisition of an editorial property by the news and financial data company in over a decade.

  • Here's Why Should You Hold MEDNAX (MD) in Your Portfolio
    Zacks

    Here's Why Should You Hold MEDNAX (MD) in Your Portfolio

    Riding high on its solid top line as well as strategic buyouts, MEDNAX (MD) holds enough potential to generate returns for investors.

  • Reduce Holdings of These 2 Stocks
    GuruFocus.com

    Reduce Holdings of These 2 Stocks

    They have underperformed the market Continue reading...

  • Why Is Mednax (MD) Up 18.9% Since Last Earnings Report?
    Zacks

    Why Is Mednax (MD) Up 18.9% Since Last Earnings Report?

    Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • MEDNAX (MD) Ties Up With Homestead to Expand in Florida
    Zacks

    MEDNAX (MD) Ties Up With Homestead to Expand in Florida

    MEDNAX (MD) collaborates with Associated Pediatricians of Homestead to provide clinical services and expand presence in Florida.

  • 7 Sickly Healthcare Stocks to Avoid
    InvestorPlace

    7 Sickly Healthcare Stocks to Avoid

    If we can be sure of one thing in 2019, it's that not all stocks are created equal.We have seen sectors rise and some of the big names falter all the same. This has certainly been a stock picker's market.And I say that knowing full well that the S&P 500 is up an impressive 26% year-to-date.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut healthcare is a tricky sector because it incorporates a variety of stocks -- from drug companies to hospitals to insurers to medical device makers. All are on different sales calendars and don't march in lockstep.The thing to watch in the sector is how the economy is doing. If people are working then they have more money, and they will use some of that money for healthcare purposes.As far as legislation that can clear up the direction of the U.S. healthcare system, that is a long way away. * 7 Marijuana Penny Stocks That Have Ridiculous Possibilities For now, it's best to stick with only the most powerful stocks the market has to offer -- and avoid the weakest. And the doctor is ordering you to banish these seven sickly healthcare stocks from your portfolio, if you've got them. Healthcare Stocks to Sell: Mednax (MD)Source: IgorGolovniov / Shutterstock.com Mednax (NYSE:MD) is a Florida-based firm that has been supplying physician services for anesthesia, pediatric specialties and newborns since 1976.These contract services have been in big demand for a while, as the healthcare landscape was developing under new "Obamacare" legislation.But those days are passed and healthcare organizations are settling in the current state of limbo. But that means staffing is a bit more predictable and MD's services are finding fewer customers.MD has begun restructuring to get back in step with market conditions. Whether that works or not, remains to be seen. But it's getting downgraded across the board and year-over-year revenue is declining. There's more downside than upside left for this stock. Fresenius Medical Care (FMS)Source: OleksandrShnuryk / Shutterstock.com Fresenius Medical Care (NYSE:FMS) has been doing pretty well this year, relative to the category it finds itself in today.This Germany-based firm specializes in treatment and services for patients with chronic kidney failure and is one of the top providers, along with DaVita (NYSE:DVA). The problem is, while this is a growth sector, especially in the United States, Medicare is tight with its payments, so the margins are low. And solid operating margins are crucial to the profitability standards I set for any investment.In July, President Donald Trump issued an executive order allowing in-home services for kidney dialysis and other treatments and both sector-leading stocks popped.But it may not be FMS that is the biggest winner, especially given the fact that its dialysis clinics and home services would initially add to costs. This is ultimately a win for insurers rather than these specialized companies. * 7 Killer Stocks No One Knows About The stock is only down 3% in the past year, but it's up 13% year-to-date, so this performance is showing a downtrend is still in place. Healthcare Services Group (HCSG)Source: Shutterstock Healthcare Services Group (NASDAQ:HCSG) is a good example of a middling company in the ancillary services sector of the healthcare industry -- including laundry and dietary services for long-term care facilities -- that has been struggling between strength and weakness for a while.It's a good sector and it is a pretty big name in the industry, having been around since 1976. But the dynamics in this sector are shifting, as the insurance industry would prefer to pay to keep people at home, rather than pay for facilities. The same goes for Medicare.Struggles with margins have been ongoing. And then in late October, third-quarter earnings hammered the company. While revenue was in line with expectations, earnings missed by almost 10%. That's not encouraging.It also means analysts cut their price targets moving forward and institutional investors are looking to move their money, further driving down the stock. Brookdale Senior Living (BKD)Source: Pavel Kapysh / Shutterstock.com Brookdale Senior Living (NYSE:BKD) provides senior living communities to more than 75,000 residents. It has been in business since 2005.During that time, BKD has been able to capture the first wave of baby boomers and the tail end of their parents heading into assisted living facilities. And this market looked like it was going to expand for decades as boomers started filling up these facilities in huge numbers.Now, real estate is an area I'd consider crucial to my Growth Investor strategy … if the business model is strong. But along the way, technology has shifted this particular trend. In-home care has increased and there is now more care that can be conducted from homes due to advances in equipment.This means assisted living facilities are under pressure. They proliferated, anticipating a growing base, and now that growth looks to be less than expected. Given the fact that they've dumped huge sums in large campuses, this is not the "sure thing" it was five years ago. * 9 Tantalizing Dividend Stocks for 2020 There will be growing competition in this sector and Medicare and insurers will have some leverage here, all challenging BKD's margins in coming quarters, if not years. HCA Healthcare (HCA)Source: Trismegist san / Shutterstock.com HCA Healthcare (NYSE:HCA) is a for-profit company that operates hospitals, urgent care facilities, outpatient services facilities and the like.It was founded in 1968 and comprises nearly 250,000 employees in 21 states, including 38,000 physicians and 87,000 nurses. It's No. 63 in the Fortune 500.This isn't a stock or company teetering on the brink of existence. But it will be in an increasingly challenging sector moving forward.The graying of America was supposed to be a boon for these types of companies. But the real challenge underneath it all is how Americans pay for all of this increased healthcare.Insurance companies are not interested in expanding the margins for hospital companies. And Medicare is already under pressure for funding as it is; more people in the system won't help its generosity.This is one of those stocks that may not fall significantly, but it won't rise much either. There are simply better places to put your money to work. Cigna (CI)Source: Piotr Swat / Shutterstock.com Cigna (NYSE:CI) is one of the leading health insurers in the U.S. and beyond. It has a $75 billion market capitalization and has been around since 1792. Nope, that not a typo, it's 227 years old.It bought the first insurer in America -- Insurance Company of North America -- in a 1982 merger. That's some serious staying power.Recently, this sector has been under duress because Wall Street was worried that Democratic presidential candidate Elizabeth Warren was going to destroy the health insurance industry with her Medicare for All health coverage program.But Warren recently laid out the plan and it looks like such an outcome would be at least three years out if she were to be elected. And that means it would be up for implementation as she ran for a second term, which gives companies even more time. * 10 Cheap Stocks to Buy Under $10 CI and other insurers were all part of a relief rally. But the fact is, the popularity of Medicare for All isn't lost on these big insurers. And it's going to be a tough transition to come up with a better private solution or figure out what to do when the current system transitions. In the meantime, I see much stronger stocks out there. Encompass Health (EHC)Source: Piotr Swat / Shutterstock.com Encompass Health (NYSE:EHC) provides post-acute healthcare services, such as inpatient and in-home rehabilitation as well as hospice care.Basically, it's part of a growth sector that benefits from the graying U.S. population as well as the trend to provide services outside brick-and-mortar corporate facilities.And its home care services are broader than simply rehabilitation. It provides nursing care as well as physical therapy. Also, its physical therapy division is available to people of all ages that are in need of rehabilitation services.The trouble is, this sector is in its early days and the industry is undergoing some volatility, given the vague future of U.S. healthcare policy, and thus, how companies can best adapt.Plus, the enthusiasm for this sector a few years ago has made stocks like EHC relatively expensive, so its valuations aren't in line with the current state of the sector. Wall Street doesn't like surprises, and this sector may be full of them in coming quarters.There are certainly worse stocks out there, but there are also better ones right now. Why I Like Dividend Growth Stocks NowIf you think what happened in the stock market the last few months is wild, just look at the bond market. We've got falling and even negative yields overseas. But as investors retreat to U.S. Treasuries it's causing bizarre effects here, too. Just look at what happened this summer, when the two-year Treasury actually began to yield MORE than the 10-year Treasury. And even the 30-year Treasury can't be relied upon for good yield anymore.So if a stock's earnings picture is uncertain, not only is it going to be volatile, but people are going to look elsewhere seeking income.Meanwhile, other stocks not only earn an "A" in my Portfolio Grader, thanks to strong buying pressure and great fundamentals …The stocks also earn an "A" in my Dividend Grader. These stocks are able to pay great yields -- and have the strong business model to back it up.All in all, I've got 29 strong dividend growth stocks for you now in Growth Investor -- averaging 4% yields -- far more than the S&P 500 or even a Treasury bond. These stocks are poised to do well as we continue to see international capital flow to the U.S. markets. Click here to see how I found these stocks, and how you can get great performance out of YOUR portfolio -- come what may.Louis Navellier had an unconventional start, as a grad student who accidentally built a market-beating stock system -- with returns rivaling even Warren Buffett. In his latest feat, Louis discovered the "Master Key" to profiting from the biggest tech revolution of this (or any) generation. Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Marijuana Penny Stocks That Have Ridiculous Possibilities * 7 High-Yield ETFs to Buy Now * 4 Dow Jones Industrial Average Stocks to Sell The post 7 Sickly Healthcare Stocks to Avoid appeared first on InvestorPlace.

  • MEDNAX's Ratings Get Affirmed by Moody's, Outlook Negative
    Zacks

    MEDNAX's Ratings Get Affirmed by Moody's, Outlook Negative

    MEDNAX (MD) receives rating affirmations from Moody's. However, the outlook is changed to negative.

  • Moody's

    MEDNAX, Inc. -- Moody's changes MEDNAX's outlook to negative, affirms ratings

    Moody's Investors Service ("Moody's") affirmed MEDNAX, Inc.'s ("MEDNAX") Ba2 Corporate Family Rating, the Ba2-PD Probability of Default Rating and the Ba2 rating on its unsecured bonds due in 2023 and 2027. At the same time, the outlook was changed to negative from stable.

  • Thomson Reuters StreetEvents

    Edited Transcript of MD earnings conference call or presentation 1-Nov-19 1:00pm GMT

    Q3 2019 MEDNAX Inc Earnings Call

  • MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y
    Zacks

    MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y

    MEDNAX's (MD) results reflect escalating expenses in the third quarter.

  • Mednax (MD) Q3 Earnings Meet Estimates
    Zacks

    Mednax (MD) Q3 Earnings Meet Estimates

    Mednax (MD) delivered earnings and revenue surprises of 0.00% and 1.75%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Why Earnings Season Could Be Great for MEDNAX (MD)
    Zacks

    Why Earnings Season Could Be Great for MEDNAX (MD)

    MEDNAX (MD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Cigna (CI) to Report Q3 Earnings: What's in the Offing?
    Zacks

    Cigna (CI) to Report Q3 Earnings: What's in the Offing?

    Cigna (CI) Q3 earnings are likely to have benefited from higher contribution across all its segments and effect of share buyback.

  • What's in Store for Molina Healthcare (MOH) Q3 Earnings?
    Zacks

    What's in Store for Molina Healthcare (MOH) Q3 Earnings?

    Molina Healthcare's (MOH) third-quarter results are likely to be affected by soft revenues, partly offset by improved marketplace business.